Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
Maureen Sinnott, O.S.F., is a retired clinical psychologist and worked as a nurse-midwife in Ireland, Taiwan and Tanzania. She is currently an advocate with the Alzheimer’s Association.